Endpoints News

Novartis to invest $480M in China following AstraZeneca and Lilly pledges

Published

2 weeks ago

on

Novartis is the latest drugmaker to invest in its Chinese footprint, with a pledge of more than 3.3 billion yuan ($480 million) to bolster two manufacturing and R&D sites.

The company will pour 1.5 billion …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version